Chronic and acute effects of thiazolidinediones BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism
Clemens Fürnsinn(Medical University of Vienna), W. Waldhäusl, Barbara Brunmair(Medical University of Vienna), P. Nowotny(University of Vienna), Susanne Neschen(Yale University), Barbara Schneider(Altonaer Kinderkrankenhaus), H.F. Kühnle(Roche Pharma AG (Germany)), Michael Roden(Düsseldorf University Hospital), M.E. Meyer(Roche Pharma AG (Germany)), Roman Furtmüller(Medical University of Vienna)
Cited by 32
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
The integrative biology of type 2 diabetes
|Nature|2019|1.1k